Cervical Cancer Screening Challenges
Cervical cancer is one of the most common cancers among women all over the world. Most cases of cervical cancer occur in countries with limited resources. Screening in areas with rich facilities in people with moderate risk is done with cytology every three years, an HPV test, or both together (co-test) every five years. Screening starts at the age of 21 and ends at the age of 65, provided that the screening is sufficient and normal. In HIV-positive and immunocompromised people, at first visit cytology and colposcopy are performed, and then cytology is done every year; if it is negative three times, it continues every three years. In areas with limited facilities, it is recommended to start screening at the age of 30 for most cases, and depending on the test used, repeat the test every 3–10 years. If two consecutive screening results are negative, screening can be stopped at age 50.
Authors
- Somayyeh Noei Teymoordash (ORCID: https://orcid.org/0000-0002-0507-5728)
- Maliheh Arab (ORCID: https://orcid.org/0000-0002-2244-3529)
- Maryam Motamedinasab
- Akram Ghahghaei‐Nezamabadi (ORCID: https://orcid.org/0000-0001-7090-8426)
- Hamid Reza Dehghan Manshadi (ORCID: https://orcid.org/0009-0001-1721-254X)
- N. Nouri (ORCID: https://orcid.org/0009-0003-1100-6328)
Institutions
- Iran University of Medical Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Obstetrics Gynecology and Cancer Research
- Published
- 2025-08-03
- DOI
- https://doi.org/10.24200/jogcr.10.9.660
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00